This commentary explores whether there is epistemic injustice in global antimicrobial resistance (AMR) research - who sets priorities, who produces knowledge, and which types of knowledge are valued. We argue that epistemic injustice may have created blind spots in policy. Addressing this requires a commitment to diversity, equity, and inclusion.
Other
2025-06-01T00:00:00+00:00
33
577 - 579
2
antimicrobial resistance, diversity, epistemic injustice, equity, ethics, inclusion, Humans, Global Health, Anti-Bacterial Agents, Knowledge, Drug Resistance, Bacterial, World Health Organization, Biomedical Research, Drug Resistance, Microbial